{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:50:54Z","timestamp":1790887854360,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82260694"],"award-info":[{"award-number":["82260694"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21977092"],"award-info":[{"award-number":["21977092"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U24A20805"],"award-info":[{"award-number":["U24A20805"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Provincial Science and Technology Support Program","doi-asserted-by":"publisher","award":["2023ZYD0042,2023NSFSC1106"],"award-info":[{"award-number":["2023ZYD0042,2023NSFSC1106"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007471","name":"Applied Basic Research Foundation of Yunnan Province","doi-asserted-by":"publisher","award":["202201AT070297"],"award-info":[{"award-number":["202201AT070297"]}],"id":[{"id":"10.13039\/100007471","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007471","name":"Applied Basic Research Foundation of Yunnan Province","doi-asserted-by":"publisher","award":["202301AW070003"],"award-info":[{"award-number":["202301AW070003"]}],"id":[{"id":"10.13039\/100007471","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ejmech.2025.117676","type":"journal-article","created":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T18:55:46Z","timestamp":1745348146000},"page":"117676","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Structural optimization and pharmacological evaluation of diphenyl amine esters as anti-hepatocellular carcinoma agents by targeting TAR RNA-binding protein 2"],"prefix":"10.1016","volume":"291","author":[{"given":"Ruihan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hairong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghui","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianze","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linhan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinqiao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwen","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weilie","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.117676_bib1","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/s41576-023-00611-y","article-title":"microRNAs in action: biogenesis, function and regulation","volume":"24","author":"Shang","year":"2023","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.ejmech.2025.117676_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13694","article-title":"TRBP ensures efficient dicer processing of precursor microRNA in RNA-Crowded environments","volume":"7","author":"Fareh","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2025.117676_bib3","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2174\/138920210793175895","article-title":"MicroRNA: biogenesis, function and role in cancer","volume":"11","author":"MacFarlane","year":"2010","journal-title":"Curr. Genom."},{"key":"10.1016\/j.ejmech.2025.117676_bib4","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.apsb.2016.09.002","article-title":"Regulation of multidrug resistance by microRNAs in anti-cancer therapy","volume":"7","author":"An","year":"2017","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2025.117676_bib5","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2174\/0115665232261931231006103234","article-title":"Current updates on the role of MicroRNA in the diagnosis and treatment of neurodegenerative diseases","volume":"24","author":"Saleem","year":"2024","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.ejmech.2025.117676_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1322806","article-title":"Challenges and promise of targeting miRNA in rheumatic diseases: a computational approach to identify miRNA association with cell types, cytokines, and disease mechanisms","volume":"14","author":"Shaikh","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2025.117676_bib7","doi-asserted-by":"crossref","first-page":"919","DOI":"10.7150\/thno.7026","article-title":"MicroRNAs -the next generation therapeutic targets in human diseases","volume":"3","author":"Srinivasan","year":"2013","journal-title":"Theranostics"},{"key":"10.1016\/j.ejmech.2025.117676_bib8","doi-asserted-by":"crossref","first-page":"256","DOI":"10.21037\/jgo.2016.09.07","article-title":"Hepatocellular carcinoma (HCC): beyond sorafenib-chemotherapy","volume":"8","author":"Kim","year":"2017","journal-title":"J. Gastrointest. Oncol."},{"key":"10.1016\/j.ejmech.2025.117676_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.694363","article-title":"Role of small molecule targeted compounds in cancer: progress, opportunities, and challenges","volume":"9","author":"Sun","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ejmech.2025.117676_bib10","doi-asserted-by":"crossref","first-page":"5537","DOI":"10.3390\/molecules27175537","article-title":"Small molecule inhibitors for hepatocellular carcinoma: advances and challenges","volume":"27","author":"Kamal","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117676_bib11","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.pharmthera.2017.02.010","article-title":"Recent advances in hepatocellular carcinoma therapy","volume":"173","author":"Dutta","year":"2017","journal-title":"Pharmacol. Therapeut."},{"key":"10.1016\/j.ejmech.2025.117676_bib12","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2011.04.026","article-title":"Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma","volume":"56","author":"Tomimaru","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejmech.2025.117676_bib13","doi-asserted-by":"crossref","first-page":"645","DOI":"10.3390\/biom12050645","article-title":"Hepatocellular carcinoma: the role of MicroRNAs","volume":"12","author":"Khare","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejmech.2025.117676_bib14","doi-asserted-by":"crossref","first-page":"971","DOI":"10.17219\/acem\/36460","article-title":"MicroRNAs in the occurrence and development of primary hepatocellular carcinoma","volume":"25","author":"Xu","year":"2016","journal-title":"Adv. Clin. Exp. Med."},{"key":"10.1016\/j.ejmech.2025.117676_bib15","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1038\/s12276-023-01050-9","article-title":"MicroRNA: trends in clinical trials of cancer diagnosis and therapy strategies","volume":"55","author":"Kim","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ejmech.2025.117676_bib16","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1038\/s41587-024-02480-0","article-title":"What will it take to get miRNA therapies to market?","volume":"42","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejmech.2025.117676_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.112008","article-title":"A review of currently identified small molecule modulators of microRNA function","volume":"188","author":"Van Meter","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117676_bib18","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/anie.201106455","article-title":"The tuberculosis drug streptomycin as a potential cancer therapeutic: inhibition of miR-21 function by directly targeting its precursor","volume":"51","author":"Bose","year":"2012","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2025.117676_bib19","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/nbt.1481","article-title":"A small molecule enhances RNA interference and promotes microRNA processing","volume":"26","author":"Shan","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejmech.2025.117676_bib20","doi-asserted-by":"crossref","first-page":"4394","DOI":"10.1073\/pnas.1014720108","article-title":"Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-Binding protein 2-mediated microRNA processing","volume":"108","author":"Melo","year":"2011","journal-title":"P. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejmech.2025.117676_bib21","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1039\/D4MD00649F","article-title":"New anti-ovarian cancer quinolone derivatives acting by modulating microRNA processing machinery","volume":"16","author":"Felicetti","year":"2024","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117676_bib22","doi-asserted-by":"crossref","first-page":"11010","DOI":"10.1021\/acs.jmedchem.2c00189","article-title":"Discovery of a novel small-molecule inhibitor disrupting TRBP- dicer interaction against hepatocellular carcinoma via the modulation of microRNA biogenesis","volume":"65","author":"Peng","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117676_bib23","doi-asserted-by":"crossref","first-page":"7404","DOI":"10.1021\/acs.jmedchem.1c00018","article-title":"Identification of a novel TAR RNA-binding protein 2 modulator with potential therapeutic activity against hepatocellular carcinoma","volume":"64","author":"Zhou","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117676_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/wcms.1468","article-title":"Next generation 3D pharmacophore modeling","volume":"10","author":"Schaller","year":"2020","journal-title":"Wires. Comput. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.117676_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112116","article-title":"A comprehensive review of miR-21 in liver disease: big impact of little things","volume":"134","author":"Xue","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejmech.2025.117676_bib26","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd.2016.246","article-title":"MicroRNA therapeutics: towards a new era for the management of cancer and other diseases","volume":"16","author":"Rupaimoole","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2025.117676_bib27","first-page":"952","article-title":"MicroRNA-22-3p and MicroRNA-149-5p inhibit human hepatocellular carcinoma cell growth and metastasis properties by regulating methylenetetrahydrofolate reductase","volume":"46","author":"Li","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.ejmech.2025.117676_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.461","article-title":"MiR-26 enhances chemosensitivity and promotes apoptosis of hepatocellular carcinoma cells through inhibiting autophagy","volume":"8","author":"Jin","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2025.117676_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-11418-3","article-title":"Molecular mechanisms governing microRNA-125a expression in human hepatocellular carcinoma cells","volume":"7","author":"Potenza","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2025.117676_bib30","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/s41419-018-0592-z","article-title":"MicroRNA-125b reverses oxaliplatin resistance in hepatocellular carcinoma by negatively regulating EVA1A mediated autophagy","volume":"9","author":"Ren","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2025.117676_bib31","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1007\/s10495-008-0256-z","article-title":"Let-7a microRNA suppresses therapeutics-induced cancer cell death by targeting caspase-3","volume":"13","author":"Tsang","year":"2008","journal-title":"Apoptosis"},{"key":"10.1016\/j.ejmech.2025.117676_bib32","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.biocel.2018.11.011","article-title":"MicroRNA-181a-5p suppresses cell proliferation by targeting Egr1 and inhibiting Egr1\/TGF-\u03b2\/Smad pathway in hepatocellular carcinoma","volume":"106","author":"Bi","year":"2019","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ejmech.2025.117676_bib33","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41420-022-01101-6","article-title":"Emerging mechanisms of pyroptosis and its therapeutic strategy in cancer","volume":"8","author":"Lu","year":"2022","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.ejmech.2025.117676_bib34","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1080\/21655979.2021.1926201","article-title":"Inhibition of micro RNA miR-122-5p prevents lipopolysaccharide-induced myocardial injury by inhibiting oxidative stress, inflammation and apoptosis via targeting GIT1","volume":"12","author":"Song","year":"2021","journal-title":"Bioengineered"},{"key":"10.1016\/j.ejmech.2025.117676_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.126953","article-title":"Linc00657 promoted pyroptosis in THP-1-derived macrophages and exacerbated atherosclerosis via the miR-106b-5p\/TXNIP\/NLRP3 axis","volume":"253","author":"Liang","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejmech.2025.117676_bib36","doi-asserted-by":"crossref","first-page":"7475","DOI":"10.1002\/jcp.27509","article-title":"OxLDL induces vascular endothelial cell pyroptosis through miR-125a-5p\/TET2 pathway","volume":"234","author":"Zhaolin","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ejmech.2025.117676_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2024.115127","article-title":"miR-135a-5p alleviates cerebral ischemia-reperfusion injury by inhibiting pyroptosis mediated through the DDX3X\/NLRP3 pathway","volume":"385","author":"Liu","year":"2025","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejmech.2025.117676_bib38","article-title":"LINC00365 promotes miR-221-5p to inhibit pyroptosis via dicer in colorectal cancer","author":"Yang","year":"2024","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"10.1016\/j.ejmech.2025.117676_bib39","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1111\/odi.13198","article-title":"miR-155 promotes macrophage pyroptosis induced by Porphyromonas gingivalis through regulating the NLRP3 inflammasome","volume":"25","author":"Li","year":"2019","journal-title":"Oral Dis."},{"key":"10.1016\/j.ejmech.2025.117676_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-015-0229-y","article-title":"MicroRNA-26a suppresses epithelial-mesenchymal transition in human hepatocellular carcinoma by repressing enhancer of zeste homolog 2","volume":"9","author":"Ma","year":"2016","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.ejmech.2025.117676_bib41","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1038\/nprot.2014.138","article-title":"The cellular thermal shift assay for evaluating drug target interactions in cells","volume":"9","author":"Jafari","year":"2014","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ejmech.2025.117676_bib42","doi-asserted-by":"crossref","first-page":"W422","DOI":"10.1093\/nar\/gkae236","article-title":"ADMETlab 3.0: an updated comprehensive online ADMET prediction platform enhanced with broader coverage, improved performance, API functionality and decision support","volume":"52","author":"Fu","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2025.117676_bib43","doi-asserted-by":"crossref","DOI":"10.1155\/2024\/6618927","article-title":"Protective effects of baicalein on lipopolysaccharide-induced AR42J PACs through attenuation of both inflammation and pyroptosis via downregulation of miR-224-5p\/PARP1","volume":"2024","author":"Liu","year":"2024","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.ejmech.2025.117676_bib44","doi-asserted-by":"crossref","first-page":"5486","DOI":"10.1038\/s41388-019-0804-8","article-title":"Impaired microRNA processing by DICER1 downregulation endows thyroid cancer with increased aggressiveness","volume":"38","author":"Ram\u00edrez-Moya","year":"2019","journal-title":"Oncogene"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425004416?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425004416?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T04:52:24Z","timestamp":1778043144000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425004416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":44,"alternative-id":["S0223523425004416"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117676","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structural optimization and pharmacological evaluation of diphenyl amine esters as anti-hepatocellular carcinoma agents by targeting TAR RNA-binding protein 2","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117676","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117676"}}